Bradley J Walsh
Overview
Explore the profile of Bradley J Walsh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
485
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shore N, Polikarpov D, Pieczonka C, Henderson R, Bailen J, Saltzstein D, et al.
Urol Oncol
. 2023 Sep;
41(11):454.e9-454.e16.
PMID: 37734979
Background: There is a clinical need to identify patients with an elevated PSA who would benefit from prostate biopsy due to the presence of clinically significant prostate cancer (CSCaP). We...
2.
Ghosh S, Fletcher N, Huda P, Houston Z, Howard C, Lund M, et al.
Mol Pharm
. 2023 Jan;
20(3):1549-1563.
PMID: 36602058
Glioblastoma (GBM) is the most aggressive form of primary brain cancer, accounting for about 85% of all primary central nervous system (CNS) tumors. With standard treatment strategies like surgery, radiation,...
3.
Sayyadi N, Justiniano I, Wang Y, Zheng X, Zhang W, Jiang L, et al.
Sci Rep
. 2022 Nov;
12(1):18452.
PMID: 36323734
Two molecular cytology approaches, (i) time-gated immunoluminescence assay (TGiA) and (ii) Raman-active immunolabeling assay (RiA), have been developed to detect prostate cancer (PCa) cells in urine from five prostate cancer...
4.
Zhang W, Campbell D, Walsh B, Packer N, Liu D, Wang Y
J Nanobiotechnology
. 2022 Oct;
20(1):446.
PMID: 36242076
Pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal cancers worldwide with high mortality, which is mainly due to the lack of reliable biomarkers for PDAC diagnosis/prognosis in the...
5.
Zhang W, Wang L, Li D, Campbell D, Walsh B, Packer N, et al.
Anal Methods
. 2022 May;
14(23):2255-2265.
PMID: 35612592
Circulating pancreatic ductal adenocarcinoma (PDAC) derived small extracellular vesicles (sEVs) are nano-sized membranous vesicles secreted from PDAC cells and released into surrounding body fluids, such as blood. The use of...
6.
Sabanathan D, Lund M, Campbell D, Walsh B, Gurney H
Ther Adv Med Oncol
. 2021 Oct;
13:17588359211022918.
PMID: 34646364
Radioimmunotherapy (i.e., the use of radiolabeled tumor targeting antibodies) is an emerging approach for the diagnosis, therapy, and monitoring of solid tumors. Often using paired agents, each targeting the same...
7.
Chen Y, Shimoni O, Huang G, Wen S, Liao J, Duong H, et al.
Cytometry A
. 2021 Sep;
101(5):400-410.
PMID: 34585823
Sensitive and quantitative detection of molecular biomarkers is crucial for the early diagnosis of diseases like metabolic syndrome and cancer. Here we present a single-molecule sandwich immunoassay by imaging the...
8.
Polikarpov D, Campbell D, Zaslavsky A, Lund M, Wu A, Lu Y, et al.
Int J Urol
. 2021 Sep;
28(12):1290-1297.
PMID: 34498294
Objectives: To investigate whether anti-glypican-1 antibody Miltuximab conjugated with near-infrared dye IRDye800CW can be used for in vivo fluorescence imaging of urothelial carcinoma. Methods: The conjugate, Miltuximab-IRDye800CW, was produced and...
9.
Sabanathan D, Campbell D, Velonas V, Wissmueller S, Mazure H, Trifunovic M, et al.
Asia Ocean J Nucl Med Biol
. 2021 Jul;
9(2):86-100.
PMID: 34250138
Objectives: Miltuximab is a chimeric antibody targeting Glypican-1 (GPC-1), a cell surface antigen which is overexpressed in solid cancers. Miltuximab has shown promising safety and efficacy in radioimmunotherapy models of...
10.
Bailey D, Sabanathan D, Aslani A, Campbell D, Walsh B, Lengkeek N
Asia Ocean J Nucl Med Biol
. 2021 Jan;
9(1):1-8.
PMID: 33392343
A limitation to the wider introduction of personalised dosimetry in theranostics is the relative paucity of imaging radionuclides with suitable physical and chemical properties to be paired with a long-lived...